Scioto Biosciences rakes in $1.8 mln Series A
Indianapolis-based Scioto Biosciences, a developer of "innovative therapies to transform the delivery of microbiome therapeutics," has raised $1.8 million in Series A financing. The investors included BioCrossroads, Elevate Ventures and Rev1 Ventures.
21 May 2018•1 min read
